Skip to main content

Guidelines & Publications

Data & Audit Publications

Copies of the annual reports on the BAUS Cancer Registry and complex operations data are available on the Data and Audit publications page.

Download the first STUKA report on partial nephrectomy

 

Improving Outcomes Guidance (IOG)

NICE has produced guidance regarding the referral and management of urological cancers by multidisciplinary teams. This includes guidance about centralisation of complex services for urological cancers.

Download the IOG document

 

NICE Guidelines

In May 2009, BAUS and NICE published a joint statement on the implementation of the NICE prostate cancer guidelines.

Download the joint statement on the implementation of the NICE Prostate Cancer Guideline

Following publication of this guideline, the Oncology Section and the British Uro-Oncology Group (BUG) sought members' opinions by means of a questionnaire.  In January 2014, following consultation with BAUS and other interested groups, guideline CG175 - Prostate cancer: diagnosis & treatment was published on the NICE website; this was updated in 2019 (see below) to reflect recent changes in diagnosing prostate cancer.

Bladder cancer managemnent View the guidance
Enzalutamide for prostate cancer View the guidance
Routine pre-operative tests for elective surgery View the guidance
Sepsis: recognition, diagnosis and early management View the guidance
Prostate cancer: diagnosis & treatment View the guidance
 

European Association of Urology (EAU) Guidelines

The EAU produces evidence-based guidelines for the management of both benign and malignant urological conditions. Being guidelines (and not protocols), they are advisory rather than proscriptive.

How to access the full EAU guidelines.

In addition, the EAU has released an app containing a "pocket" version of its guidelines; to obtain this app, go to your provider's App Store and search for "EAU Pocket Guidelines".

Individual guidelines relevant to the Section can be downloaded using the links in the table below:

Bladder cancer: muscle invasive & metastatic View the guidance
Bladder cancer: non-muscle invasive (TaT1) View the guidance
Lasers & technology View the guidance
Penile cancer View the guidance
Renal cell carcinoma View the guidance
Robotic & single-site surgery View the guidance
Testicular cancer View the guidance
Upper urinary tract urothelial cancer View the guidance
Primary urethral carcinoma View the guidance
Thromboprophylaxis View the guidance
Infographic for the risk of thrombosis & bleeding in urological surgery (ROTBUS) View the graphic
 

BAUS Section of Oncology Guidance

The BAUS Section of Oncology Executive Committee were approached by GIRFT in 2021 to promote an SoC-based streamlining to urological cancer MDT working. 

Following consultation with Section members, the article (currently in proof form) has been accepted for JCU publication under the title of "BAUS Oncology Guidance for Implementing Streamlining in Cancer MDT meetings: Selecting  Standards of Care and Operational Considerations" and was published on 2 May 2-3

Download the article (member login required)

 

UK & EAU Guidelines Compared

In March 2018, the Journal of Clinical Urology (JCU) published a series of commisioned articles by British urologists in which the current UK and European Association of Urology guidelines were compared. Comparisons relevant to this Section are listed below.  

Click an item to view a PDF of the full article published in the Journal of Clinical Urology Vol 11(2); 81-153. Individual articles have a facility to check for updates by clicking on the appropriate button in the top left corner of the text:

     

    Latest Publication News

    Consultant Job Planning 2024

    A message from Ian Pearce, BAUS Vice President: The original version of A Guide to Job Planning for Consultant Urologists - written by Kieran...